Oramed will release its PhII data for insulin pill this week; Medac Pharma submits NDA for arthritis injection;

> Medac Pharma had its NDA accepted by the FDA for a subcutaneous injectable methotrexate and injection device for arthritis. More

> Oramed is set to announce the results of a Phase IIa trial for oral insulin this week. Release

> 3-D Matrix filed a patent infringement complaint against Menicon and B-Bridge International for its self-assembling peptide technology. Release

> Researchers in Iran published a study in the journal RSC Advances that shows the utility of a biodegradable heparin-coated nanocomposite system for targeted drug delivery to tumors. Abstract